Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tmunity Therapeutics
Biotech
Gilead's Kite swoops in to buy CAR-T focused Tmunity
Kite Pharma is buying Carl June-founded Tmunity for an undisclosed sum, accessing the University of Pennsylvania's research apparatus in the process.
Max Bayer
Dec 20, 2022 8:00am
Biopharma charts progress in translating CAR-T to solid cancers
Dec 15, 2021 3:00am
Founder-led biotech makes space for ideas—and diverse leaders
Nov 23, 2021 7:00am
Tmunity stops solid tumor CAR-T trial after 2 patients die
Jun 3, 2021 8:40am
Tmunity expands Penn pact, picking up another CAR-T program
Feb 9, 2021 10:10am
Biopharma targets cancer with next-gen cell therapies
Sep 14, 2020 4:15pm
